Clinical Trial of ssCART-19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia (Including Central Nervous System Infiltration)
Conditions: Relapsed or Refractory Acute Lymphoblastic Leukemia; Leukemia Patients With Central Nervous System Infiltration Interventions: Biological: ssCART-19; Drug: Fludarabine; Drug: Cyclophosphamide Sponsors: Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd; The First Affiliated Hospital of Soochow University; Peking University People ' s Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Clinical Trials | Hospitals | Leukemia | Research